Solid Tumor Malignancies

Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy

A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors

GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors

A Clinical Study of GO321 in Patients With Advanced Solid Tumors

Exploring the Feasibility of Cerebrospinal Fluid (CSF) and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and Primary Central Nervous System (CNS) Tumours: A Pilot Study

ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis

Clinical Evaluation of [68Ga]Ga-FFD PET Imaging in Healthy Volunteers and Patients With Solid Tumors

A Phase I/II Study of FG-M108 Plus FG-B901 in Advanced CLDN18.2-Positive Solid Tumors

GKL-006Allo Injection in Patients With Advanced Solid Tumors

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

xDRIVE for Florida-based Cancer Patients

ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter

ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies